-
Mashup Score: 1Round Table Discussion on Aerolase Energy-Based Devices For Comprehensive Skincare Treatments for Fitzpatrick Skin Types I-VI. - 2 month(s) ago
At the core, our devices focus on dermatologic conditions, requiring more effective therapeutic options and more acceptable to patient standards and levels of safety. Aerolase develops scalable, leading-edge devices for forward-thinking medical professionals who want to deliver top-of-the-line therapies, immeasurable patient experiences, and incredible patient results for all things skin-related. We develop lasers with everything you need to take your work to the next level power, capability, and
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0XDEMVY Experts: Real-World Patient and MD Perspectives - 2 month(s) ago
Featuring six intricate case presentations and engaging seven expert panelists in invigorating discussions, this live, interactive, virtual event will act as a practical and pivotal guide for surgeons. We aim to educate ophthalmologists on how to navigate unexpected complications in a calm and calculated fashion, turning what might seem overwhelming into something that looks routine the next day.
Source: events.avenue.liveCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5IL-31: An important neuroimmune cytokine in prurigo nodularis and atopic dermatitis - 3 month(s) ago
This article is authored by Dr. Baldo Scassellati Sforzolini, M.D., Ph.D., MBA, Global Head of R&D, Galderma and Dr. Christophe Piketty, M.D., Ph.D., Global Senior Program Head at Galderma. IL-31 is a neuroimmune cytokine that drives the most burdensome symptom in prurigo nodularis and atopic dermatitis, namely itch, and is also involved in skin inflammation and keratinocyte abnormalities.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 6IL-31: An important neuroimmune cytokine in prurigo nodularis and atopic dermatitis - 4 month(s) ago
This article is authored by Dr. Baldo Scassellati Sforzolini, M.D., Ph.D., MBA, Global Head of R&D, Galderma and Dr. Christophe Piketty, M.D., Ph.D., Global Senior Program Head at Galderma. IL-31 is a neuroimmune cytokine that drives the most burdensome symptom in prurigo nodularis and atopic dermatitis, namely itch, and is also involved in skin inflammation and keratinocyte abnormalities.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1RED 72 Reperfusion Catheter with SENDit Technology - 4 month(s) ago
RED 72 is now available with SENDit Technology. SENDit is designed to simplify preparation and ease delivery of RED 72.
Source: www.penumbrainc.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 5What is GelX? - GelX - 4 month(s) ago
GelX® is a mucoprotectant brand available in a 100ml oral solution spray, indicated for the prevention and treatment of oral mucositis and suitable for use in all ages and all ethnic cultures. 1 Provides a bio-adhesive barrier for durable protection Blocks exposed nerve endings and coats oral lesions to soothe…
Source: gelxuk.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, Salivary Biomarkers - 5 month(s) ago
Understanding these relationships is crucial for developing effective clinical management strategies for patients with AD, according to a recent literature review.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 2
Please fill out the information below as you would like it to appear in the meeting materials, then click next to continue.Physician (post-training): For practicing and retired physicians from non-sponsoring companiesFellow: For physicians currently in a fellowship training programResident: For physicians currently in a residency training programFaculty: For invited ACRC and Macula 2024 guest…
Source: mcpi.cventevents.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Home - 5 month(s) ago
How do your atopic dermatitis management strategies compare with those of your peers? Join us for a live, case-based workshop and work through case challenges with your colleagues. Our faculty experts will guide discussion through common case scenarios, patient assessment strategies, and treatment options for patients with moderate-to-severe atopic dermatitis. Don’ t miss out! This activity is intended for nurse practitioners, physician assistants, and other advanced practice providers involved in the
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1Home - 6 month(s) ago
How do your atopic dermatitis management strategies compare with those of your peers? Join us for a live, case-based workshop and work through case challenges with your colleagues. Our faculty experts will guide discussion through common case scenarios, patient assessment strategies, and treatment options for patients with moderate-to-severe atopic dermatitis. Don’ t miss out! This activity is intended for nurse practitioners, physician assistants, and other advanced practice providers involved in the
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet
#ad Aerolase’s energy-based devices give dermatologists options when treating Fitzpatrick Skin Types I-VI. Learn more with this expert-led roundtable discussion: https://t.co/Q2FIHI3F8v https://t.co/5ul0XDxknJ